ExodusPoint Capital Management, LP - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 276 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$2,053
-14.2%
51,315
-5.9%
0.01%
-22.2%
Q1 2024$2,394
+214.6%
54,531
+343.5%
0.02%
+260.0%
Q4 2023$761
+238.2%
12,296
+151.7%
0.01%
+150.0%
Q3 2023$225
-79.8%
4,886
-74.8%
0.00%
-77.8%
Q2 2023$1,114
+173.7%
19,381
+33.5%
0.01%
+50.0%
Q4 2022$407
-99.9%
14,515
+14.0%
0.01%
-14.3%
Q2 2020$286,00012,7320.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
MQS Management LLC 10,935$255,0000.41%
GLOBEFLEX CAPITAL L P 144,692$3,370,0000.34%
CORNERCAP INVESTMENT COUNSEL INC 58,975$1,374,0000.20%
Factorial Partners, LLC 10,900$254,0000.17%
FEDERATED HERMES, INC. 3,464,335$80,684,0000.15%
Campbell & CO Investment Adviser LLC 14,800$345,0000.12%
FULLER & THALER ASSET MANAGEMENT, INC. 611,462$14,241,0000.08%
Summit Global Investments 45,900$1,069,0000.07%
RENAISSANCE GROUP LLC 63,559$1,480,0000.06%
PDT Partners, LLC 33,459$779,0000.06%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders